A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

505

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
ObesityOverweightDiabetes Mellitus, Type 2
Interventions
DRUG

Naltrexone SR 32 mg/bupropion SR 360 mg/ day

DRUG

Placebo

BEHAVIORAL

Ancillary therapy

Ancillary therapy consisting of diet instruction, advice on behavior modification, and exercise counseling

Trial Locations (53)

11365

Diabetes care and Information Center, Flushing

13104

Central New York Clinical Research, Manlius

14609

Rochester Clinical Research, Inc, Rochester

21209

Health Trends Research, LLC, Baltimore

28209

Metrolina Medical Research, Charlotte

29349

Mountain View Clinical Research, Greer

29464

Palmetto Medical Research, Mt. Pleasant

30909

CSRA Partners in Health, Inc, Augusta

33024

University Clinical Research, Pembroke Pines

33143

Miami Research Associates, Miami

33907

LCFP Inc., Fort Myers

34684

Suncoast Clinical Research, Palm Harbor

36532

SelfCenter, PC, Fairhope

37203

Clinical Research Associates, Inc., Nashville

37404

ClinSearch, Chattanooga

40213

L-Marc, Louisville

40509

Central Kentucky Research Associates, Inc., Lexington

42431

Trover Center for Clinical Studies, Madisonville

43213

Central Ohio Nutrition Center, Inc., Columbus

44060

Your Diabetes Endocrine and Nutrition Group, Mentor

44122

Rapid Medical Research, Inc., Cleveland

45429

Wells Institute for Health Awareness, Kettering

46383

Northwest Indiana Center for Clinical Research, Valparaiso

47713

Deaconess Clinic, Evansville

55430

Twin Cities Clinical Research, Brooklyn Center

63141

Mercy Health Research, St Louis

Radiant Research, Inc., St Louis

64114

The Center for Pharmaceutical Research, Kansas City

70458

Medical Research Institute, Slidell

70808

Pennington Biomedical Research Center, Baton Rouge

71913

HealthStar Research, Hot Springs

75230

The Cooper Institute, Dallas

75246

Baylor Endocrine Center, Dallas

78217

InVisions Consultants, LLC, San Antonio

79705

Diabetes Center of the Southwest, Midland

85050

HOPE Research Institute, Phoenix

85381

Pivotal Research Centers, Peoria

87108

Lovelace Scientific Resources, Albuquerque

89557

Center for Nutrition and Metabolic Diseases, Univ. of Nevada, Reno

90211

Impact Clinical Trials, Beverly Hills

92108

Affiliated Research Institute, San Diego

92161

VA San Diego Healthcare System, San Diego

92705

Apex Research Institue, Santa Ana

92869

Advance Clinical Research Institute, Orange

93710

Sierra Medical Research, Fresno

96814

East-West Medical Research Institute, Honolulu

98104

Summit Research Network, Inc., Seattle

98608

Northern California Research, Carmichael

99208

Northside Internal Medicine, Spokane

06708

Chase Medical Research, LLC, Waterbury

01103

FutureCare Studies, Springfield

03820

Endocrinology & Diabetes Consultants, Dover

78229-4801

Diabetes & Glandular Disease Research Associates, Inc., San Antonio

Sponsors
All Listed Sponsors
lead

Orexigen Therapeutics, Inc

INDUSTRY